in vitro , decreased cytochrome oxidase activity, increased ROS generation and impaired mitochondrial reducing capacity ( via ER stress (Webber et al., 2006)
It may also treat symptoms of Parkinsons disease by reducing the frequency and severity of a patients tremor (x)
Peak serum concentrations (2550 mcg/mL) are achieved within an hour after 1 g intramuscular dose (Waters and Tadi, 2024)
External resources FDA Prescribing Information for Zepbound (tirzepatide) including OSA indication SURMOUNT-OSA Trial Results (New England Journal of Medicine) For researchers serious about optimizing every aspect of their peptide protocols, SeekPeptides offers the most comprehensive resource available, with evidence-based guides covering side effect management, dosing optimization, and community support from thousands of experienced researchers
Navarro P, Billette C, Ferrer N, Savoie JM (2014) Characterization of the aap1 gene of Agaricus bisporus , a homolog of the yeast YAP1